Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.01
↑ 96% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-27.28
Historical baseline
PeriodValueYoY Change
2024-1.01+71.6%
2023-3.56+30.5%
2022-5.12-99.0%
2021-2.57+96.7%
2020-78.62-7.9%
2019-72.83-